Why did healthcare stocks and funds plunge sharply in the closing session on December 15? Was any negative news released? I’m nearly wiped out!

Today’s healthcare stocks were truly ‘life-threatening’! The $20-billion IPO of BeiGene plummeted immediately upon opening, plunging nearly 20% intraday—resulting in a loss of ¥18,000 per subscription. We thought things couldn’t get worse—but then, in the afternoon, ‘the king of China’s pharma sector,’ WuXi AppTec (market cap: ¥400 billion), suddenly crashed and hit its daily trading limit down. On the Hong Kong exchange, WuXi Biologics plunged a staggering 20%. The entire sector followed suit. When something highly unusual happens, there’s always a hidden cause. After digging into the details, ‘Huashao’ discovered—once again—it’s the U.S. stirring up trouble. At mid-afternoon on the 15th, with absolutely no warning, this ¥400-billion giant—the leading Chinese CXO company WuXi AppTec—plunged vertically and hit its daily limit down; meanwhile, WuXi Biologics on the Hong Kong exchange also nosedived straight down by 20%! The whole sector tumbled along with them. 1.0 Underlying factors suppressing sector sentiment recently Over the past six months, the healthcare sector has performed poorly overall, driven primarily by two key reasons: First, repeated ‘blow-ups’ among industry leaders. Take Tongce Medical—the so-called ‘Tooth King’—as an example: its Q3 report showed revenue of ¥820 million, up 12.44% year-on-year, but net profit attributable to shareholders stood at ¥269 million, rising only 5.88% YoY. Following this announcement, Tongce Medical’s stock hit two consecutive daily limit-downs—and from the day the Q3 report was released, its share price fell over 28%. Second, actions by prominent shareholders. According to Q3 reports disclosed by Keyuan Pharmaceutical, Tigermed, and Aier Eye Hospital, Hillhouse Capital has exited the top-ten circulating shareholders list of all three companies. As a premier investment institution, Hillhouse’s entry or exit from holdings is always closely watched by the market—thus triggering investor anxiety and concern about the broader healthcare sector. 2.0 What should investors do? Overall, the reported U.S. sanctions remain unconfirmed and are still unfolding. If it turns out to be false information, today’s indiscriminate sell-off may present a buying opportunity. If true, however, investors must carefully assess the potential impact on fundamentals—especially whether it will materially affect earnings—before drawing any conclusions.

Dow Inc. Q3 2025 Earnings Report (October 27, 2025)

After languishing for a full year—falling two major tiers—the stock surged 13% following the Q3 2025 earnings release. Has anything meaningfully changed in the fundamentals? • First, revenue came in weak: the Q2 guidance for this quarter had been $10.2 billion. • Second, GAAP EPS turned positive this quarter only due to two non-recurring items; operating profit failed to cover interest expenses. • On the bright side, the loss was narrower than expected—the company’s cost-cutting and capital expenditure reduction initiatives have proven effective. Has the chemical industry reached a cyclical downturn inflection point? • On the supply side, Dow believes capacity restraint is now underway across multiple regions—including China: ‘We’ve seen speculation about closures totaling roughly 13 million metric tons—comprising approximately 5 million tons of additional capacity in Asia, Japan, and Korea, plus around 7 million tons in China stemming from [anti-evolution] policies.’ • On the demand side, Dow views overall demand as still weak—with no change from last quarter. It hopes interest-rate cuts will stimulate construction starts.

Dow Inc Falls After Four Sessions; Healthcare Stocks Decline

Oct 13, 2026

Dow Inc shares declined after a four-session winning streak, accompanied by a general decrease in healthcare-related stocks, indicating a minor downturn in specific U.S. market sectors.

Moomoo

2026-04-27

Dow Inc. Stock Falls $62 Amid U.S.-Iran Talk Uncertainty

2026-04-28

Dow Inc. (DOW) stock moves -1.30%: What you should know

2026-04-28

Dow Inc. Shares Drop $26 Amid Market Caution Over Middle East and AI

2026-04-29

U.S. Stocks: Dow Inc. Continues to Decline, Down 280 Points, Amid Concerns Over Prolonged Energy Supply Disruptions (September 29)

2026-04-29

Dow Inc (DOW) Shares Surge 4.0% -- What GF Score of 64 Tells Investors